Meeting NewsVideo

VIDEO: Research highlights from ATA

CHICAGO — In this video exclusive, Endocrine Today Editorial Board Member Stephanie L. Lee, MD, PhD, FACE, ECNU, professor of medicine and director of thyroid health in the section of endocrinology, diabetes and nutrition at Boston Medical Center, discusses four important studies presented at the American Thyroid Association Annual Meeting.

In one, researchers found an increased risk for pancreatitis among patients taking methimazole. In another study, researchers have demonstrated that anaplastic thyroid cancer in a subset of patients with BRAF V600E mutations can resolve with a new therapeutic regimen. Impressive data for a new medication for thyroid eye disease were presented in another session. Finally, another speaker described factors that minimize risks in PET-differentiated thyroid cancers.

Disclosure: Lee reports no relevant financial disclosures.

CHICAGO — In this video exclusive, Endocrine Today Editorial Board Member Stephanie L. Lee, MD, PhD, FACE, ECNU, professor of medicine and director of thyroid health in the section of endocrinology, diabetes and nutrition at Boston Medical Center, discusses four important studies presented at the American Thyroid Association Annual Meeting.

In one, researchers found an increased risk for pancreatitis among patients taking methimazole. In another study, researchers have demonstrated that anaplastic thyroid cancer in a subset of patients with BRAF V600E mutations can resolve with a new therapeutic regimen. Impressive data for a new medication for thyroid eye disease were presented in another session. Finally, another speaker described factors that minimize risks in PET-differentiated thyroid cancers.

Disclosure: Lee reports no relevant financial disclosures.

    See more from American Thyroid Association